Here are relevant reports on : clinical-trials-market
-
Rigid Endoscopes Market by Type (Laparoscopes, Arthroscopes, Cystoscopes), Clinical Usage (Diagnostic, Surgical), Application (Laparoscopy, Cystoscopy, Arthroscopy, Other), End User (Hospitals, ASCs, Clinics), Region - Global Forecast to 2030
The global rigid endoscopes market, valued at US$1.76 billion in 2024, stood at US$1.83 billion in 2025 and is projected to advance at a resilient CAGR of 4.9% from 2025 to 2030, culminating in a forecasted valuation of US$2.32 billion by the end of the period. The growth of the rigid endoscopes market is driven by increasing procedural volumes resulting from the rise in chronic pulmonary and urological conditions, as well as growing patient preference for minimally invasive diagnostics
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Behavioral Health Software Market by Component (Services, Software), Delivery (Subscription, Ownership), Functionality (Clinical, EHR, CDS, Telehealth, RCM, BI, Administrative, Financial), End User (Hospitals, Clinics) - Global Forecasts to 2026
The global behavioral health software market growth is primed to transition from $2.0 billion in 2021 to $4.9 billion by 2026, showcasing a strong CAGR of 19.6%. Factors such as the increasing adoption of behavioral health software, availability of government funding, government initiatives to encourage EHR adoption in behavioral health organizations, medical professionals are putting a greater emphasis on providing patients with mental illness with high-quality care, favourable behavioral health reforms in the US, and high demand for mental health services amidst provider shortage are driving the growth of this market.
- Published: June 2021
- Price: $ 4950
- TOC Available:
-
Stable Isotope Labeled Compounds Market by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute), Region – Global Forecast to 2024
The global stable isotope labeled compounds market in terms of revenue was estimated to be worth $269 million in 2019 and is poised to reach $312 million by 2024, growing at a CAGR of 3.0% from 2019 to 2024. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: January 2020
- Price: $ 4950
- TOC Available:
-
Lateral Flow Assay Components Market by Type (Membrane, Pad), Application (Clinical Testing (Infectious, Cardiac Marker Test, Fertility, Pregnancy, Cholesterol Testing), Veterinary, Food Safety), Technique, End User & Region - Global Forecast to 2030
The global lateral flow assay components market, valued at US$378.4 million in 2024, stood at US$392.4 million in 2025 and is projected to advance at a resilient CAGR of 4.4% from 2025 to 2030, culminating in a forecasted valuation of US$486.2 million by the end of the period. Market growth is driven by increasing health awareness and the shift toward lifestyle and home-based healthcare, as more consumers adopt self-monitoring and rapid testing solutions.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals), Region - Global Forecast to 2030
The global Artificial Intelligence (AI) in healthcare market, valued at US$14.92B in 2024, is forecasted to grow at a 38.6% CAGR, reaching US$21.66B by 2025 and US$110.61B by 2030. Market growth in the Asia Pacific can be attributed to the presence of a large and growing patient population, a gradual shift toward adopting technologies such as automation, data analytics, and cloud computing, and increasing spending on HCIT infrastructure.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Clinical Manufacturing Services Market by Finished Dosage Formulations (Tablets, Capsules, Oral Dosages), Type (Analytical Services, Formulation Development, Stability/Storage), End-User (Pharmaceuticals Biopharmaceuticals) - Global Forecast to 2023
In the face of limited resources, the pharmaceutical companies have been recently focusing on the areas of their core competency in drug research and development. The capital-intensive nature of pharmaceutical drug R&D activities have created a need to outsource clinical stage manufacturing of drugs. Clinical manufacturing services include development of formulations for clinical trials, analysis of those formulations and their solubility and stability testing services.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Healthcare IT Market by Solution (Provider, Payer; Clinical (EHR, PHM, PACs & VNA, Telehealth, RCM, CDSS); Nonclinical (Analytics, Pharmacy, Interoperability), Service (Claim, Billing, Supply), End user (Hospital, Payer) - Global Forecast to 2029
The global healthcare IT market, valued at US$368.15 billion in 2023, stood at US$420.23 billion in 2024 and is projected to advance at a resilient CAGR of 14.7% from 2024 to 2029, culminating in a forecasted valuation of US$834.35 billion by the end of the period. The growth of the market is mainly driven by technological advancements, rising adoption of telehealth solutions, and increasing importance of user-generated digital health data.
- Published: November 2024
- Price: $ 8150
- TOC Available:
-
Clinical Trial Management System Market by Product (Software, Services), Delivery (Web-hosted, On-premise, Cloud-based), Deployment (Enterprise, On-site), End User (Pharma, Medical Device Manufacturers, CROs) & Region - Global Forecast to 2025
The global clinical trial management system market growth is primed to transition from $801 million in 2020 to $1.59 billion by 2025, showcasing a strong CAGR of 14.7%. The growth of this market is driven by the increasing number of clinical trials and government support for research trials. However, budget constraints and limited knowledge about advanced CTMS solutions restrain the market's growth.
- Published: January 2021
- Price: $ 4950
- TOC Available:
-
Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) & Geography - Global Forecast to 2022
The clinical laboratory services market is expected to reach USD 146.41 billion by 2022 from USD 113.4 billion in 2017, at a CAGR of 5.2% during the forecast period. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), DaVita Healthcare Partners (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), Cerba HealthCare (France), and among others
- Published: December 2017
- Price: $ 4950
- TOC Available:
-
North American Healthcare IT Market by Solution (Provider, Payer (Clinical (EHR, PHM, PACS & VNA, Telehealth, RCM, CDSS), Nonclinical (Analytics, Pharmacy, Interoperability)), Service (Claim, Billing)), End User (Hospital, Payer) - Global Forecast to 2030
The global North American healthcare IT market, valued at US$202.12 billion in 2024, stood at US$229.05 billion in 2025 and is projected to advance at a resilient CAGR of 13.9% from 2025 to 2030, culminating in a forecasted valuation of US$439.09 billion by the end of the period. The growth of this market can be attributed to increasing awareness about digital health, government mandates, financial incentives for adopting healthcare IT solutions, and a shift toward value-based care.
- Published: June 2025
- Price: $ 6150
- TOC Available:
Records 31 to 40 of 50
